P2.41 (also presented as PD1.06): Pembrolizumab vs Docetaxel for Previously Treated NSCLC (KEYNOTE-010): Archival vs New Tumor Samples for PD-L1 Assessment

Slides:

Advertisements

Similar presentations

P3.02c-063 Lactate Dehydrogenase (LDH) as a Surrogate Biomarker to Checkpoint- Inhibitors for Patient with Advanced Non–Small-Cell Lung Cancer (NSCLC)

Advertisements

Prognostic Significance of PD-L1 in Patients with Non–Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases Jong-Mu Sun, MD, Wei.

SC17.02 Lung Cancer in China: Challenges and Perspectives

Journal of Thoracic Oncology Volume 11, Issue 4, Pages (April 2016)

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

P3.02b-001 Phase 1 Dose Escalation of PF (EGFR-T790M Inhibitor) in Patients with Advanced EGFRm (Del 19 or L858R+/-T790M) NSCLC Hatim Husain,

P Comparison of Peri-Operative Outcomes after Robotic-Assisted Video- Thoracoscopic Lobectomies versus Segmentectomies Maria Echavarria, Anna.

Journal of Thoracic Oncology Volume 12, Issue 3, Pages (March 2017)

MA12.06 Tumor Spread through Air Spaces (STAS) in Lung Squamous Cell Cancer is an Independent Risk Factor: A Competing Risk Analysis Shaohua Lu, Takashi.

First-Line Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status Young Joo Lee, MD, Heung Tae Kim, MD,

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

P Transcriptional Profiling Identified the Anti-Proliferative Effect of Mitofusin-2 Deficiency and Its Risk in Lung Adenocarcinoma Yuqing Lou,

P3.02c-030 Use of a 200-Mg Fixed Dose of Pembrolizumab for the Treatment of Advanced Non–Small Cell Lung Cancer (NSCLC) Edward Garon, Martin Reck, Delvys.

P The Effect of Two Interventions on Attainment of Surgical Quality Measures in Resected Non-Small Cell Lung Cancer (NSCLC) Nicholas Faris, Meredith.

P3.02a-036 Phase 1 Study of Ceritinib 450 mg or 600 mg Taken with a Low-Fat Meal versus 750 mg in Fasted State in ALK+ Metastatic NSCLC Rafal Dziadziuszko,

MA13.01 Markerless Tumor Tracking during Lung Radiotherapy Using Intrafraction X- Ray Imaging Chun-Chien (Andy) Shieh, Vincent Caillet, Michelle Dunbar,

PUB023 Effectiveness of Three-Dimensional Video System in Single Port Thorascopic Major Pulmonary Resection: Propensity Score Matched Analysis Hyun Koo.

P3.02c-088 Acquired Resistance to Programmed Death-1 Axis Inhibitors in Non-Small Cell Lung Cancer (NSCLC) Jungmin Choi, Ryan Sowell, Anna Truini, Kurt.

Journal of Thoracic Oncology Volume 12, Issue 5, Pages (May 2017)

Confessions of a journal junkie

P Molecular Characterization of Non-Small Cell Lung Cancers (NSCLC) in Young Patients from an Argentine Population V. Denninghoff, G. Recondo,

Journal of Thoracic Oncology Volume 13, Issue 2, Pages (February 2018)

MA17.03 Identifying Genomic Alteration and Inter-Tumor Heterogeneity of Multiple Primary Lung Cancers by Targeted NGS of Tumor Tissue and ctDNA Kezhong.

P3.02b-075 Addition of Bevacizumab for Malignant Pleural Effusion as the Manifestation of Acquired EGFR-TKI Resistance in NSCLC Patients Tao Jiang, Shengxiang.

P3.02a-012 Patient-Reported Symptoms and Quality of Life (QoL) in East Asian Patients with ALK+ NSCLC Treated with Crizotinib vs Chemotherapy You Lu,

In This Issue Journal of Thoracic Oncology

Journal of Thoracic Oncology Volume 11, Issue 2, Pages (February 2016)

Support Your Specialty

P1.22: Temporal Survival Improvement for Stage-II (T3N0M0) Lung Adenocarcinoma After Pulmonary Lobectomy Danny T. Nguyen, Jacques-Pierre Fontaine, Lary.

Journal of Thoracic Oncology Volume 12, Issue 7, Pages (July 2017)

Journal of Thoracic Oncology Volume 12, Issue 8, Pages (August 2017)

ED11.01 Systemic Therapy for Advanced Oncogene-Driven NSCLC

JCSE01.16 Positive Correlation Between Whole Genomic Copy Number Variant Scoring and the Grading System in Lung Non-Mucinous Invasive Adenocarcinoma

Journal of Thoracic Oncology Volume 11, Issue 10, Pages (October 2016)

P Assessment of Lung Tumor Motion Comparing 4DCT, 4DCBCT and Motion of Implanted Beacons during Imaging and Irradiation Elisabeth Steiner, Chun-Chien.

ES Lung Cancer Surgery for High Risk Patients

Journal of Thoracic Oncology Volume 12, Issue 10, Pages (October 2017)

P2.35: Nivolumab vs Docetaxel in Advanced NSCLC: CheckMate 017/057 2-Y Update and Exploratory Cytokine Profile Analysis Hossein Borghaei, Julie Brahmer,

P Comparison of Pulmonary Function after Robotic-Assisted Video- Thoracoscopic Lobectomies vs Segmentectomies Maria Echavarria, Anna Cheng, Frank.

Journal of Thoracic Oncology Volume 11, Issue 5, Pages (May 2016)

Journal of Thoracic Oncology Volume 11, Issue 8, Pages (August 2016)

Journal of Thoracic Oncology

M. Kusumoto Journal of Thoracic Oncology

OA07.06 In Early-Stage Lung Adenocarcinomas, Survival by Tumor Size (T) is Further Stratified by Tumor Spread through Air Spaces Takashi Eguchi, Koji.

P Differentially Expressed microRNAs in Lung Adenocarcinoma Invert Effects of Copy Number Aberrations of Prognostic Genes Tomas Tokar, Emily.

Table of Contents Journal of Thoracic Oncology

MA12.05 Can Tumor Spread through Air Spaces (STAS) in Lung Adenocarcinomas Be Predicted Pre- and Intraoperatively? Koji Kameda, Shaohua Lu, Takashi Eguchi,

International Thymic Malignancies Interest Group: A Way Forward

Journal of Thoracic Oncology Volume 13, Issue 3, Pages (March 2018)

P Impact of Systematic EBUS-TBNA Mediastinal Staging on Radical Radiotherapy Planning in NSCLC N. Hardcastle, A. Cole, G. Turgeon, R. Thomas,

P Implications of 8th Edition TNM Proposal: Invasive vs

OA Video-Assisted Thoracoscopic Surgery vs

Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed.

MA02.10 The First Year of Implementing a Lung Cancer Screening Program in an Urban Safety-Net Health System H. Hamann, S. Lee, T. Browning, C. Chavez,

P Combined Molecular and Radiological Evaluation Unveils Three Subtypes of Disease Progression to a Third Generation EGFR TKI Y. Zhang, Q. Zhou,

Journal of Thoracic Oncology Volume 13, Issue 6, Pages (June 2018)

PS01.07 The Clinical Necessity of Extended Thymectomy for Thymic Squamous Cell Carcinomas Revealed by Exome Sequencing J. Jiang, Y. Zhang, C. Jin, J.

Journal of Thoracic Oncology

3A.01 Efficacy of Programmatic Combined Stereotactic Ablative Radiotherapy and Anti- PD-1 Therapy in Advanced Lung Cancer: A Retrospective Analysis A.

IASLC 6th Latin American Conference on Lung Cancer

P Clinical Consequences, Quality of Life, and Management of Neutropenic NSCLC Patients in the REVEL Trial D. Ettinger, O. Arrieta, N. Karaseva,

P Post-Recurrence Survival Analysis of Stage I Non-Small Cell Lung Cancer: Prognostic Significance of Local Treatment Kanghoon Lee, Hyeong Ryul.

PUB006 Impact of the New WHO Classification of Thymic Tumors: Cross-Validation of the Prognostic Value in a Single Institution Cohort Mohamed Kamel,

Toward a more rational approach in treating type B aortic dissection

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

P1.15: Comparison of Pulmonary Function After Robotic-Assisted Video-Thoracoscopic Lobectomies vs Segmentectomies Maria F. Echavarria, Anna Cheng, Frank.

P1. 02: Lung Cancer - A Previously Years Survival Study

Y. Lou, R. Manochakian, J. Cochuyt, D. Hodge, S. Ailawadhi

Robert Comis, MD, The Passing of a “Lung Man”

ED04.01 Surgery in Bronchopulmonary Typical and Atypical Carcinoids

Presentation transcript:

P2.41 (also presented as PD1.06): Pembrolizumab vs Docetaxel for Previously Treated NSCLC (KEYNOTE-010): Archival vs New Tumor Samples for PD-L1 Assessment Roy S. Herbst, Paul Baas, Jose L. Perez-Gracia, Enriqueta Felip, Dong-Wan Kim, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn, Margarita Majem, Mary Jo Fidler, Veerle Surmont, Gilberto De Castro, Marcelo Garrido, Yue Shentu, Marisa Dolled-Filhart, Ellie Im, Edward B. Garon Journal of Thoracic Oncology Volume 11, Issue 10, Pages S242-S243 (October 2016) DOI: 10.1016/j.jtho.2016.08.112 Copyright © 2016 Terms and Conditions

Journal of Thoracic Oncology 2016 11, S242-S243DOI: (10. 1016/j. jtho Copyright © 2016 Terms and Conditions